About
Akagera Medicines is a Rwanda-founded biotechnology company that develops novel and patented liposomal formulations of antibacterial drugs targeting tuberculosis and other infectious diseases, with laboratories in the US and operations in Rwanda including future manufacturing and clinical trials.
Explore Akagera Medicines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.